Banner - Collaborative Care Symposium
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Alexandra Ward, VP of content

Advertisement

Articles by Alexandra Ward, VP of content

Ocular findings of COVID-19

ByNicholas Colatrella, OD, FAAO, Dipl AAO, ABO, ABCMO,Jeffrey Varanelli, OD, FAAO, Dipl ABO, ABCMO,Alexandra Ward, VP of content
November 5th 2021

COVID-19 affects every part of the eye, front to back.

The optometrist’s role in diagnosing and treating hypertension

ByTodd Peabody, OD, MBA, FAAO,Richard Meetz, OD, MS, FAAO,Alexandra Ward, VP of content
November 5th 2021

ODs have the rare opportunity to engage as well as educate patients on hypertension.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Optometry Times - Clinical News & Expert Optometrist Insights

    1

    Dompé enrolls first patients in phase 3 trial of Isocyclosporin for atopic keratoconjunctivitis

    2

    What advancements optometrists are hoping for in 2026: Part 1

    3

    “Family business?” Navigating the business of treating family

    4

    FDA extends Aldeyra's reproxalap PDUFA after requesting additional clinical study report

    5

    Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA

    • Advertise
    • About Us
    • Editorial
    • Contact Us
    • Job Board
    • Terms & Conditions
    • Privacy
    • Do not sell my Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    • Ophthalmology Times
    • Modern Retina
    • Optometry Times
    • Ophthalmology Times Europe
    Collaborative Care Symposium
    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us